11/6
04:30 pm
srzn
Surrozen to Present at Upcoming Healthcare Investor Conferences
Low
Report
Surrozen to Present at Upcoming Healthcare Investor Conferences
11/6
09:00 am
srzn
Surrozen Provides Third Quarter 2024 Financial Results and Business Update
Medium
Report
Surrozen Provides Third Quarter 2024 Financial Results and Business Update
11/4
08:42 am
srzn
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary Fibrosis [Yahoo! Finance]
Medium
Report
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary Fibrosis [Yahoo! Finance]
11/4
08:30 am
srzn
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary Fibrosis
Medium
Report
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary Fibrosis
9/24
09:08 am
srzn
Surrozen earns $10M milestone payment through Boehringer collaboration [Seeking Alpha]
Low
Report
Surrozen earns $10M milestone payment through Boehringer collaboration [Seeking Alpha]
9/24
08:30 am
srzn
Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration
Medium
Report
Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration